Evidence Details for IGHMBP2
Basic Information Top
| Gene Symbol: | IGHMBP2 ( CATF1,FLJ34220,FLJ41171,HCSA,HMN6,SMARD1,SMUBP2 ) |
|---|---|
| Gene Full Name: | immunoglobulin mu binding protein 2 |
| Band: | 11q13.3 |
| Quick Links | Entrez ID:3508; OMIM: 600502; Uniprot ID:SMBP2_HUMAN; ENSEMBL ID: ENSG00000132740; HGNC ID: 5542 |
| Relate to Another Database: | SFARIGene; denovo-db |
Sequences Top
>IGHMBP2|3508|nucleotide
ATGGCCTCGGCAGCTGTGGAGAGCTTCGTGACCAAGCAACTGGACCTGCTGGAGCTTGAGAGAGACGCGGAGGTGGAGGAGCGCAGGTCCTGGCAGGAGAACATC
TCTCTGAAAGAGCTCCAGAGCCGAGGCGTGTGTTTGCTGAAGCTGCAGGTATCCAGCCAGCGCACTGGGCTGTACGGACGGCTGCTGGTCACCTTTGAGCCCAGG
CGATACGGGTCCGCGGCAGCTCTTCCCAGTAACAGCTTTACTTCTGGTGATATCGTGGGCCTGTACGATGCTGCTAATGAGGGCAGTCAGCTGGCCACTGGGATC
TTGACCCGGGTCACCCAGAAGTCGGTCACGGTGGCCTTTGATGAGTCCCACGATTTCCAGTTGAGCTTGGACCGAGAGAATTCCTACAGACTGTTAAAACTTGCC
AATGATGTCACTTACAGGCGACTGAAAAAAGCCCTGATTGCTCTAAAGAAGTATCATTCTGGCCCAGCCTCCTCACTCATAGAAGTGCTCTTTGGCAGATCTGCT
CCCAGTCCTGCCAGTGAAATACACCCGCTGACATTCTTCAACACCTGCCTGGACACCTCCCAGAAAGAAGCGGTTTTATTTGCGCTGTCTCAGAAAGAACTTGCC
ATCATCCATGGACCTCCTGGCACTGGGAAAACCACGACTGTGGTTGAGATCATTCTTCAAGCTGTGAAACAAGGCTTAAAGGTTCTGTGCTGCGCCCCCTCCAAC
ATCGCCGTGGACAATCTGGTGGAGCGCCTGGCTCTGTGTAAGCAGCGGATTCTGCGCCTGGGACACCCTGCCCGCCTCCTGGAGTCCATTCAGCAGCACTCCCTG
GATGCGGTTTTAGCGCGGAGCGACAGTGCCCAGATTGTTGCAGATATCAGGAAGGACATCGACCAGGTCTTTGTGAAAAACAAAAAGACCCAGGATAAGAGAGAG
AAAAGTAATTTTCGAAATGAAATTAAGCTGTTAAGAAAAGAACTGAAGGAGAGGGAAGAAGCAGCTATGCTCGAGAGCCTCACTTCGGCAAACGTGGTCCTTGCA
ACAAACACAGGTGCGTCTGCCGATGGCCCCCTGAAGTTGCTGCCCGAGAGCTACTTCGACGTGGTGGTCATTGACGAGTGTGCCCAGGCCCTCGAGGCGAGCTGC
Show »
ATGGCCTCGGCAGCTGTGGAGAGCTTCGTGACCAAGCAACTGGACCTGCTGGAGCTTGAGAGAGACGCGGAGGTGGAGGAGCGCAGGTCCTGGCAGGAGAACATC
TCTCTGAAAGAGCTCCAGAGCCGAGGCGTGTGTTTGCTGAAGCTGCAGGTATCCAGCCAGCGCACTGGGCTGTACGGACGGCTGCTGGTCACCTTTGAGCCCAGG
CGATACGGGTCCGCGGCAGCTCTTCCCAGTAACAGCTTTACTTCTGGTGATATCGTGGGCCTGTACGATGCTGCTAATGAGGGCAGTCAGCTGGCCACTGGGATC
TTGACCCGGGTCACCCAGAAGTCGGTCACGGTGGCCTTTGATGAGTCCCACGATTTCCAGTTGAGCTTGGACCGAGAGAATTCCTACAGACTGTTAAAACTTGCC
AATGATGTCACTTACAGGCGACTGAAAAAAGCCCTGATTGCTCTAAAGAAGTATCATTCTGGCCCAGCCTCCTCACTCATAGAAGTGCTCTTTGGCAGATCTGCT
CCCAGTCCTGCCAGTGAAATACACCCGCTGACATTCTTCAACACCTGCCTGGACACCTCCCAGAAAGAAGCGGTTTTATTTGCGCTGTCTCAGAAAGAACTTGCC
ATCATCCATGGACCTCCTGGCACTGGGAAAACCACGACTGTGGTTGAGATCATTCTTCAAGCTGTGAAACAAGGCTTAAAGGTTCTGTGCTGCGCCCCCTCCAAC
ATCGCCGTGGACAATCTGGTGGAGCGCCTGGCTCTGTGTAAGCAGCGGATTCTGCGCCTGGGACACCCTGCCCGCCTCCTGGAGTCCATTCAGCAGCACTCCCTG
GATGCGGTTTTAGCGCGGAGCGACAGTGCCCAGATTGTTGCAGATATCAGGAAGGACATCGACCAGGTCTTTGTGAAAAACAAAAAGACCCAGGATAAGAGAGAG
AAAAGTAATTTTCGAAATGAAATTAAGCTGTTAAGAAAAGAACTGAAGGAGAGGGAAGAAGCAGCTATGCTCGAGAGCCTCACTTCGGCAAACGTGGTCCTTGCA
ACAAACACAGGTGCGTCTGCCGATGGCCCCCTGAAGTTGCTGCCCGAGAGCTACTTCGACGTGGTGGTCATTGACGAGTGTGCCCAGGCCCTCGAGGCGAGCTGC
Show »
>IGHMBP2|3508|protein
MASAAVESFVTKQLDLLELERDAEVEERRSWQENISLKELQSRGVCLLKLQVSSQRTGLYGRLLVTFEPRRYGSAAALPSNSFTSGDIVGLYDAANEGSQLATGI
LTRVTQKSVTVAFDESHDFQLSLDRENSYRLLKLANDVTYRRLKKALIALKKYHSGPASSLIEVLFGRSAPSPASEIHPLTFFNTCLDTSQKEAVLFALSQKELA
IIHGPPGTGKTTTVVEIILQAVKQGLKVLCCAPSNIAVDNLVERLALCKQRILRLGHPARLLESIQQHSLDAVLARSDSAQIVADIRKDIDQVFVKNKKTQDKRE
KSNFRNEIKLLRKELKEREEAAMLESLTSANVVLATNTGASADGPLKLLPESYFDVVVIDECAQALEASCWIPLLKARKCILAGDHKQLPPTTVSHKAALAGLSL
SLMERLAEEYGARVVRTLTVQYRMHQAIMRWASDTMYLGQLTAHSSVARHLLRDLPGVAATEETGVPLLLVDTAGCGLFELEEEDEQSKGNPGEVRLVSLHIQAL
Show »
MASAAVESFVTKQLDLLELERDAEVEERRSWQENISLKELQSRGVCLLKLQVSSQRTGLYGRLLVTFEPRRYGSAAALPSNSFTSGDIVGLYDAANEGSQLATGI
LTRVTQKSVTVAFDESHDFQLSLDRENSYRLLKLANDVTYRRLKKALIALKKYHSGPASSLIEVLFGRSAPSPASEIHPLTFFNTCLDTSQKEAVLFALSQKELA
IIHGPPGTGKTTTVVEIILQAVKQGLKVLCCAPSNIAVDNLVERLALCKQRILRLGHPARLLESIQQHSLDAVLARSDSAQIVADIRKDIDQVFVKNKKTQDKRE
KSNFRNEIKLLRKELKEREEAAMLESLTSANVVLATNTGASADGPLKLLPESYFDVVVIDECAQALEASCWIPLLKARKCILAGDHKQLPPTTVSHKAALAGLSL
SLMERLAEEYGARVVRTLTVQYRMHQAIMRWASDTMYLGQLTAHSSVARHLLRDLPGVAATEETGVPLLLVDTAGCGLFELEEEDEQSKGNPGEVRLVSLHIQAL
Show »
Evidence summary Top
Click the link of the category-specific score to view different category of evidences. The categories without any evidences are hidden by default.
| Evidences | Syndromic Gene | GWAS | CNV | Linkage | Association | Expression | NGS de novo | NGS Mosaic | NGS Other | Low-Scale Gene Studies | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Score (No. of Studies) | No | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (1) | 0 (0) | 0 (0) | 0 (1) | 0 (0) | 1 (2) |
Syndromic Autism Gene Top
Genome-Wide Association Studies(By Ethnic Group) Top
CNV Studies Top
Linkage Studies Top
Low Scale Association Studies (by Ethnic Group) Top
Large Scale Expression Studies Top
Microarray Studies: 1
| Reference | Source | Tissue | #Subjects (% Women) |
ADI-R | ADOS | Endo- pheno | Diagnosis | Normal Controls (% Women) |
Fold Change | Up/ Down | P/Q value | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baron, 2006_1 | America | human EBV-transformed lymphoblastoid cell lines | 3 (33.33%) | ![]() | ![]() | - | autism | 3 (33.33%) |
-1.48 | Down | 0.03 | |
| ||||||||||||
Proteomics Studies:0
| Reference | Source | Tissue | Platform | #Subjects (% Women) |
ADI-R | ADOS | Diagnosis | Normal Controls(% Women) | |
|---|---|---|---|---|---|---|---|---|---|
| No Evidence. | |||||||||
NGS de novo Mutation Studies Top
NGS Mosaic SNV Studies Top
NGS Other Studies Top
| Reference | Source | Platform | ADI-R | ADOS | Diagnosis | Family | Affected | Validation Method | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | Simplex | Multiplex | ||||||||
| Toma C, 2014 | - | Illumina HiSeq 2000 | - | - | ASD | 10 | - | - | 21 | - |
Low Scale Gene Studies Top
Contact Us if you are an author of a study regarding this gene and do not find your study in this table or find errors in the representation of your study details.



